Now Available as Commure Engage, Rx.Health Uses AI and Automation to Streamline Clinical Care Coordination for Payors, Providers, and Life Science Organizations
Commure, Inc., a leading healthcare technology company committed to connecting, protecting, and empowering…
Healthcare is rapidly changing due to a highly competitive market – not to mention evolving consumer expectations, differing care models, and the need for platforms to meet different clinical and research demands.THE PROBLEM
Mount Sinai…
What You Should Know:
– Commure, Inc., a healthcare technology company acquires intelligent clinical automation platform Rx.Health and is now part of its suite of solutions as Commure Engage. Financial details of the acquisition were…
Continue Reading
By Shania Kennedy
October 31, 2023 – Mount Sinai researchers have demonstrated that publicly trained large language models (LLMs) can identify the pain location and pain location of musculoskeletal conditions like shoulder, knee, and lower back…
Continue Reading
Mount Sinai researchers have pioneered an AI tool, “HistoAge,” featured in Acta Neuropathologica, capable of estimating brain age, predicting age at death, and identifying age-related brain changes. By analyzing 700 hippocampal section images from…
Continue Reading
By Shania Kennedy
October 23, 2023 – Researchers at Mount Sinai have developed an artificial intelligence (AI) tool that can estimate histopathological brain age, predict age at death, and identify areas of the brain vulnerable to…
Continue Reading
By Shania Kennedy
October 12, 2023 – Researchers from the Mount Sinai Icahn School of Medicine and the University of Michigan have found that the deployment of predictive analytics tools may influence the predictive capabilities of…
Continue Reading
What You Should Know:
– Researchers at the Icahn School of Medicine at Mount Sinai and the University of California San Diego have been awarded an $8.5 million grant to create a data integration hub…
Continue Reading
Mount Sinai has teamed up with the Chiba Institute of Technology to integrate artificial intelligence (AI) into cardiovascular research, aiming to accelerate patient care and treatment innovations. This collaboration holds global significance in addressing…
Continue Reading
The Icahn School of Medicine at Mount Sinai has signed a memorandum of understanding with the Chiba Institute of Technology to use artificial intelligence to enhance clinical trials for cardiovascular disease, advance patient care…
Continue Reading
